logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Parambir S. Dulai

northwestern university

58H指数
550论文数
1.5W被引数
收录论文 251
发表时间
logo
Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy与BCMA car-t细胞治疗相关的小肠结肠炎中粘膜car-t细胞的持久性和炎症重塑
errNature Medicine
IF50
err2026-09-23
err0
PREAI
errNikhit Kethidi; Saumya Pothukuchi; Adolfo Aleman; Daniel Charytonowicz; Christina Kuhn; Thomas Wong; Jennifer Claytor; Pablo Canales-Herrerias; Samane Khoshbakht; Akanksha Acharya; Michael Tankelevich; Tin Htwe Thin; Divya Jha; Matthias Ceulemans; Alexandra E. Livanos; Catherine Le Berre; Zachary M. Avigan; Luise Fischer; Jacqueline E. Birkness-Gartman; Joanna Melia; Yimei Jin; Rachel Chen; Isha Parikh; Meenakshi Mehrotra; Erika Patel; Shriya Desai; Sidorela Reci; Kedwin Ventura; Rudra Prasad Dutta; Benjamin Gordon; Rachel Brody; Charlotte Cunningham-Rundles; Zhihong Chen; Seunghee Kim-Schulze; Parambir S. Dulai; Shruti Naik; Jane Houldsworth; Maximilian Merz; Randy S. Longman; Ivan Zanoni; Jeremiah Faith; Jean-Frederic Colombel; Britta Siegmund; Raja Atreya; Markus F. Neurath; Shambavi Richard; Sundar Jagannath; Jerome C. Martin; Eric Meffre; Mayte Suarez-Farinas; David Muniz Pedrogo; Alexandros D. Polydorides; Samir Parekh; Saurabh Mehandru
err分享
err收藏
Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia鉴定人类肺结核性肺泡肺炎中一个空间组织的TREM2相关允许性巨噬细胞生态位
errNature Communications
IF15.7
err2026-08-21
err0
errOAAI
errRosane M. B. Teles; Chaouki Benabdessalem; Jonathan Perrie; Cenfu Wei; Julie West; Bruno J. de Andrade Silva; Priscila R. Andrade; Lilah A. Mansky; Prajan Divaka; Linda Fischbacher; Karen Lam; Feiyang Ma; Yiqian Gu; Kimia Rategh; Madeline Brown; Aparna Pillai; Kapongo Lumamba; Threnesan Naidoo; Samuel M. French; Emna Romdhane; Mohamed-Ridha Barbouche; Eynav Klechevsky; Marco Colonna; Adrie J. C. Steyn; Steven J. Bensinger; Daniel L. Barber; Soumaya Rammeh; Parambir S. Dulai; Bryan D. Bryson; Matteo Pellegrini; John T. Belisle; Barry R. Bloom; Robert L. Modlin
err分享
err收藏
Butyrate epigenetically licenses sustained epithelial-T cell crosstalk for intestinal immune tolerance丁酸盐通过表观遗传机制许可持续的上皮细胞-T细胞串扰以实现肠道免疫耐受
errNature Communications
IF15.7
err2026-07-15
err0
errOAAI
errTianming Yu; Wenjing Yang; Anthony J. Bilotta; Suxia Yao; Jeong-Heon Lee; Qihong Zhao; Jia Zhou; Tamas Ordog; Parambir S. Dulai; Yingzi Cong
err分享
err收藏
A decade of clinical data with vedolizumab: the past, present, and future维得利珠单抗十年临床数据：过去、现在与未来
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-25
err0
PREAI
errVipul Jairath; Alessandro Armuzzi; Christian Agboton; Brian Bressler; Silvio Danese; Parambir S. Dulai; Marlies Meyer; Itzel Romo Bautista; Raja Atreya; Brian G. Feagan
err分享
err收藏
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn’s disease维多利珠单抗临床决策支持工具预测克罗恩病患者的临床相关靶点
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-04
err0
PREAI
errParambir S. Dulai; Giorgos Bamias; Vipul Jairath; Anthony Buisson; Marlies Meyer; Dirk Lindner; Christian Agboton; Laurent Peyrin-Biroulet
err分享
err收藏
Comparative effectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity-matched cohort study美基珠单抗和瑞莎珠单抗在溃疡性结肠炎患者中的比较疗效：一项倾向性匹配队列研究
errIndian Journal of Gastroenterology
IF2.1
err2026-05-01
err0
PREAI
errKochhar, Gursimran S.; Dulai, Parambir S.; Khataniar, Himsikhar; Desai, Aakash
err分享
err收藏
Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials炎症性肠病的空间转录组学图集，以指导研究联盟和临床试验的实施
errNature Communications
IF15.7
err2026-04-28
err0
errOAAI
errYiming Li; Cenfu Wei; Wenjing Yang; Hai Wang; Alan Robinson; Isabella Peshek; Tianming Yu; Jiwoon Park; Jenny Yanyi Ding; Stephen B. Hanauer; Emanuelle Bellaguarda; Laura Yun; Ronen Sumagin; Guang-Yu Yang; Christopher E. Mason; James D. Lewis; Deyu Fang; Yingzi Cong; Yuan Luo; Parambir S. Dulai
err分享
err收藏
Geometrically Encoded Positioning of Introns, Intergenic Segments, and Exons in the Human Genome (Adv. Sci. 6/2026)
errAdvanced Science
IF14.1
err2026-01-31
err0
errOAAI
errLuay M. Almassalha; Kyle L. MacQuarrie; Marcelo Carignano; Cody L. Dunton; Ruyi Gong; Joe Ibarra; Lucas M. Carter; Wing Shun Li; Rikkert Nap; Parambir S. Dulai; Igal Szleifer; Vadim Backman
err分享
err收藏
Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trial溃疡性结肠炎患者内镜梅奥评分1分且伴有活动性组织学炎症者，其结局与梅奥评分2分的轻中度患者相似：VARSITY试验的事后分析
errEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
IF1.8
err2026-01-01
err0
PREAI
errWong, Emily C. L.; Khan, Nazmus; Dulai, Parambir S.; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
err分享
err收藏
Safety of Janus kinase inhibitors compared to biologic therapy in patients with inflammatory bowel disease与生物制剂治疗相比，炎性肠病患者中Janus激酶抑制剂的用药安全性
errIntestinal Research
IF3.9
err2026-01-01
err0
PREAI
errKochhar, Gursimran S.; Khataniar, Himsikhar; Dulai, Parambir S.; Desai, Aakash
err分享
err收藏
Impact of prior inadequate response to advanced therapies on early symptomatic improvement with obefazimod induction in moderately to severely active ulcerative colitis: results from the two Phase 3 placebo-controlled ABTECT induction trials既往对先进疗法反应不足对奥贝芬尼诱导早期症状改善的影响：中度至重度活动性溃疡性结肠炎的ABTECT诱导试验III期安慰剂对照试验结果
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errAtreya, R.; Sands, B. E.; Rubin, D. T.; Dubinsky, M. C.; Armuzzi, A.; Treton, X.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Hlavaty, T.; Witek, R.; Dulai, P.; Danese, S.
err分享
err收藏
Pooled analysis of efficacy and safety of once-daily oral obefazimod in North American patients from the ABTECT Phase 3, double-blind, placebo-controlled induction trials北美ABTECT III期、双盲、安慰剂对照诱导试验中奥贝非米德每日一次口服给药的疗效和安全性的合并分析
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errSands, B. E.; Dubinsky, M. C.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Panaccione, R.; Ritter, T. E.; Siddiqui, J.; Duvall, G. A.; Dulai, P.
err分享
err收藏
Impact of baseline disease extent on efficacy of obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from ABTECT-1 and ABTECT-2 phase 3 trials基线疾病范围对中度至重度活动性溃疡性结肠炎患者奥贝膦酸酯疗效的影响：ABTECT-1和ABTECT-2 III期试验的合并结果
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errHeeren, S.; Dulai, P.; Neneman, B.; Bunganic, B.; Pumprla, J.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Peyrin-Biroulet, L.
err分享
err收藏
Obefazimod induction therapy for moderately to severely active ulcerative colitis: pooled analysis of inflammatory biomarkers from the two ABTECT Phase 3 double-blind, placebo-controlled induction trials奥贝法齐莫德诱导治疗中重度活动性溃疡性结肠炎：两项ABTECT III期双盲、安慰剂对照诱导试验中炎症生物标志物的合并分析
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errSiegmund, B.; Atreya, R.; Cataldi, F.; Jacobstein, D.; Santo, J.; Rabbat, C.; Shan, K.; Miheller, P.; Gilletta De Saint Joseph, C.; Wojnarska, B. G.; Verstockt, B.; Magro, F.; Dulai, P.
err分享
err收藏
Unsupervised Machine Learning to Identify Distinct Response Patterns to Guselkumab in Participants With Crohn's Disease: Post Hoc Analysis of the Pooled GRAVITI and GALAXI 2/3 Studies基于无监督机器学习识别克罗恩病患者对Guselkumab的不同反应模式：GRAVITI和GALAXI 2/3研究的合并数据事后分析
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-12-01
err0
PREAI
errDulai, Parambir S.; D'haens, Geert; Reinisch, Walter; Hart, Ailsa; Rani, Sudheer; Olurinde, Mobolaji; Van Rampelbergh, Rian; Gao, Long-Long; Yang, Zijiang; Hoops, Timothy; Valiathan, Chandni; Schreiber, Stefan
err分享
err收藏
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)奥贝非齐莫德在患有中度至重度活动性溃疡性结肠炎患者中的疗效与安全性：来自两项为期8周的诱导治疗期3期、随机、双盲、安慰剂对照试验（ABTECT-1和2）的结果
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-12-01
err0
PREAI
errSands, Bruce E.; Danese, Silvio; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Hisamatsu, Tadakazu; Tilg, Herbert; Atreya, Raja; Armuzzi, Alessandro; Treton, Xavier; Baert, Filip; Seidler, Ursula; Cataldi, Fabio; Jacobstein, Doug; Rabbat, Christopher J.; Shan, Kejia; Duvall, George Aaron; Siegmund, Britta; Dulai, Parambir S.; Rubin, David; Vermeire, Severine
err分享
err收藏
Proactive Patient Engagement to Promote Representative Populations in a Community Setting-Based Study of Vedolizumab in Patients With Inflammatory Bowel Disease主动患者参与以促进代表性人群在社区环境为基础的研究中，评估vedolizumab在炎症性肠病患者中的应用
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-12-01
err0
PREAI
errDulai, Parambir S.; Chen, Brian; Yajnik, Vijay; Young, Lisa; Mccue, Maggie; Blair, Chris; Gower, Megan
err分享
err收藏
Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis血清和组织嗜酸性粒细胞增多作为溃疡性结肠炎对Mirikizumab应答的预测生物标志物
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-11-01
err0
PREAI
errWong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
err分享
err收藏
Geometrically Encoded Positioning of Introns, Intergenic Segments, and Exons in the Human Genome几何编码的人基因组中内含子、基因间区段和外显子的定位
errAdvanced Science
IF14.1
err2025-10-27
err0
errOAAI
errLuay M. Almassalha; Kyle L. MacQuarrie; Marcelo Carignano; Cody L. Dunton; Ruyi Gong; Joe Ibarra; Lucas M. Carter; Wing Shun Li; Rikkert Nap; Parambir S. Dulai; Igal Szleifer; Vadim Backman
err分享
err收藏
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice克罗恩病简单内镜评分修正乘数的综述及其在临床试验和实践中的应用方法
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-10-01
err0
PREAI
errHuan, Peter W.; Mehta, Akash; Wong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Reinisch, Walter; Narula, Neeraj
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
Rob Knight
H 指数: 255 · 论文数: 1.8K
W
William J. Sandborn
H 指数: 199 · 论文数: 2.1K
M
M. Hassan Murad
H 指数: 184 · 论文数: 1.4K
S
Séverine Vermeire
H 指数: 163 · 论文数: 2.4K
R
Rohit Loomba
H 指数: 154 · 论文数: 1.3K
查看更多